Literature DB >> 3967661

Characterization of human glucosylsphingosine glucosyl hydrolase and comparison with glucosylceramidase.

A M Vaccaro, M Muscillo, K Suzuki.   

Abstract

Properties of glucosylsphingosine (gluco-psychosine) glucosyl hydrolase were studied in detail in cultured human fibroblasts and placenta and were compared with those of glucosylceramidase. The two activities, that are deficient in tissues of Gaucher patients, showed minor but consistent differences. The pH optima were 4.8 for psychosine hydrolysis and 5.3 for glucosylceramide hydrolysis. In the presence of oleic acid, taurocholate activated glucosylceramidase more than 10-fold, while it activated psychosine hydrolysis only by about 30%. Triton X-100 was stimulatory for glucosylceramidase but was strongly inhibitory for psychosine hydrolysis. Phospholipids, that increase many times glucosylceramidase activity, were moderately inhibitory to enzymatic hydrolysis of psychosine. The psychosine hydrolase activity was slightly more heat-stable than the glucosylceramidase activity. The Km values for the two substrates were similar; 1.7 X 10(-5) M for psychosine and 2.7 X 10(-5) M for glucosylceramide. The V for glucosylceramide was, however, 100-times that for psychosine hydrolysis. Psychosine acted as a potent non-competitive inhibitor (Ki = 1.8 X 10(-5) M), while glucosylceramide was a weak inhibitor against psychosine hydrolysis. Within the limit of glucosylceramide solubility, psychosine hydrolysis could not be inhibited by more than 50%. Furthermore, the Dixon plot of glucosylceramide inhibition showed an anomalous slope. The ratio of the two activities was similar in fibroblasts, in the placenta mitochondria-lysosomal fraction and in a partially purified placental preparation. These findings are best explained by the hypothesis that, although the two substrates are hydrolyzed by a single enzyme, they share an overlapping but not identical catalytic site while binding to hydrophobic sites unique for the respective substrates.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3967661     DOI: 10.1111/j.1432-1033.1985.tb08655.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  9 in total

1.  Ex vivo and in vivo effects of isofagomine on acid β-glucosidase variants and substrate levels in Gaucher disease.

Authors:  Ying Sun; Benjamin Liou; You-Hai Xu; Brian Quinn; Wujuan Zhang; Rick Hamler; Kenneth D R Setchell; Gregory A Grabowski
Journal:  J Biol Chem       Date:  2011-12-13       Impact factor: 5.157

2.  Lowered humidity produces human epidermal equivalents with enhanced barrier properties.

Authors:  Richard Sun; Anna Celli; Debra Crumrine; Melanie Hupe; Lillian C Adame; Sally D Pennypacker; Kyungho Park; Yoshikazu Uchida; Kenneth R Feingold; Peter M Elias; Dusko Ilic; Theodora M Mauro
Journal:  Tissue Eng Part C Methods       Date:  2015-01       Impact factor: 3.056

3.  Elevated plasma glucosylsphingosine in Gaucher disease: relation to phenotype, storage cell markers, and therapeutic response.

Authors:  Nick Dekker; Laura van Dussen; Carla E M Hollak; Herman Overkleeft; Saskia Scheij; Karen Ghauharali; Mariëlle J van Breemen; Maria J Ferraz; Johanna E M Groener; Mario Maas; Frits A Wijburg; Dave Speijer; Anna Tylki-Szymanska; Pramod K Mistry; Rolf G Boot; Johannes M Aerts
Journal:  Blood       Date:  2011-08-25       Impact factor: 22.113

4.  Intravenous infusion of iPSC-derived neural precursor cells increases acid β-glucosidase function in the brain and lessens the neuronopathic phenotype in a mouse model of Gaucher disease.

Authors:  Yanyan Peng; Benjamin Liou; Venette Inskeep; Rachel Blackwood; Christopher N Mayhew; Gregory A Grabowski; Ying Sun
Journal:  Hum Mol Genet       Date:  2019-10-15       Impact factor: 6.150

5.  Acute acidification of stratum corneum membrane domains using polyhydroxyl acids improves lipid processing and inhibits degradation of corneodesmosomes.

Authors:  Jean-Pierre Hachem; Truus Roelandt; Nanna Schürer; Xu Pu; Joachim Fluhr; Christina Giddelo; Mao-Qiang Man; Debra Crumrine; Diane Roseeuw; Kenneth R Feingold; Theodora Mauro; Peter M Elias
Journal:  J Invest Dermatol       Date:  2009-09-10       Impact factor: 8.551

6.  In situ visualization of glucocerebrosidase in human skin tissue: zymography versus activity-based probe labeling.

Authors:  Jeroen van Smeden; Irini M Dijkhoff; Richard W J Helder; Hanin Al-Khakany; Daphne E C Boer; Anne Schreuder; Wouter W Kallemeijn; Samira Absalah; Herman S Overkleeft; Johannes M F G Aerts; Joke A Bouwstra
Journal:  J Lipid Res       Date:  2017-10-12       Impact factor: 5.922

Review 7.  Gaucher disease: Basic and translational science needs for more complete therapy and management.

Authors:  Gregory A Grabowski; Armand H M Antommaria; Edwin H Kolodny; Pramod K Mistry
Journal:  Mol Genet Metab       Date:  2020-12-29       Impact factor: 4.797

8.  Neuronopathic Gaucher disease in the mouse: viable combined selective saposin C deficiency and mutant glucocerebrosidase (V394L) mice with glucosylsphingosine and glucosylceramide accumulation and progressive neurological deficits.

Authors:  Ying Sun; Benjamin Liou; Huimin Ran; Matthew R Skelton; Michael T Williams; Charles V Vorhees; Kazuyuki Kitatani; Yusuf A Hannun; David P Witte; You-Hai Xu; Gregory A Grabowski
Journal:  Hum Mol Genet       Date:  2010-01-04       Impact factor: 6.150

9.  Glucosylsphingosine Causes Hematological and Visceral Changes in Mice-Evidence for a Pathophysiological Role in Gaucher Disease.

Authors:  Jan Lukas; Claudia Cozma; Fan Yang; Guido Kramp; Anja Meyer; Anna-Maria Neßlauer; Sabrina Eichler; Tobias Böttcher; Martin Witt; Anja U Bräuer; Peter Kropp; Arndt Rolfs
Journal:  Int J Mol Sci       Date:  2017-10-20       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.